A Review of Sodium Oxybate and Baclofen in the Treatment of Sleep Disorders

E-ISSN： 1873-4286|17|15|1430-1435

ISSN： 1381-6128

Source： Current Pharmaceutical Design, Vol.17, Iss.15, 2011-05, pp. : 1430-1435

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Studies examining GABAB receptor agonists have reported effects on sleep including decreased sleep onset latency (SOL), increased sleep consolidation and increases in slow wave sleep (SWS). &ggr;-hydroxybutyrate (GHB) is proposed to act as a GABAB receptor agonist; however, the mechanism of action of GHB is controversial. In addition, the GABAB receptor agonist, baclofen, has also been proposed to exert similar effects on sleep. The aim of this paper is to provide a review of the human clinical studies of sodium oxybate and baclofen regarding sleep and the treatment of sleep disorders including narcolepsy and insomnia, as well as other disorders involving disrupted sleep such as fibromyalgia.